UCI rejects Froome's defense and sends Sabutamol case to Anti-Doping Court
The UCI has rejected Chris Froome’s explanations as unfounded and refered his case to CAS, the anti-doping court, French newspaper Le Monde has reported
Sky and Froome had hoped the UCI would find there were no grounds to penalise the four-time Tour de France winner, instead the UCI have opened the door to disciplinary proceedings by sending the adverse doping test Froome returned at the Vuelta a Espana last season to the Court for Arbitration in Sport.
In previous cases, Diego Ulissi tested positive for a similar level of the same drug, salbutamol, at the Giro in 2014 and was banned for nine months by a Swiss disciplinary panel. In the 2007 Giro, Alessandro Petacchi tested positive for salbutamol and was then banned for a year by the Italian authorities.
Froome had around twice the allowed amount of asthma drug salbutamol in his urine when tested on September 7 on his way to victory in the Vuelta. He argued there were natural reasons for this.
The 32-year-old Froome insists there was no wrongdoing on his or the team’s part. He is allowed to continue competing until the case is decided upon.
“It is well known that I have asthma and I know exactly what the rules are. I use an inhaler to manage my symptoms and I know for sure that I will be tested every day I wear the race leader’s jersey,” Froome said when the news of the finding broke.
"My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my salbutamol dosage. As always, I took the greatest care to ensure that I did not use more than the permissible dose.”
The UCI looked into Team Sky’s arguments and has dismissed them, Le Monde reported, after the dossier was scrutinised by their independent LADS (legal anti doping services), which was established in 2015, Le Monde reported.
The case will go to CAS and although no date has been set it would appear there will be no ruling in time to stop Froome competing at the Giro d’Italia, which starts in Jerusalem May 4.
German judge Ulrich Haas will oversee the case according to French sports daily L’Equipe.
World Anti Doping Agency director general Olivier Rabin said of the adverse salbutomol finding that “the rule has been established for a long time, the allowed level has not changed and similar cases have already been judged by CAS.”